

More on AI, COVID-19, and Revised Research Practices
Mar 26, 2020
Dive into how AI is revolutionizing drug development in the fight against COVID-19. The discussion also navigates the ethical tightrope of privacy versus safety in workplace screenings during the pandemic. Discover advances in healthcare robotics, like Diligent Robotics' assistive robot Moxie, and the essential role of open access to COVID-19 research. Plus, learn about the shift to virtual AI conferences and the proactive efforts of the robotics community in crisis response. It's a fascinating look at AI's impact in these challenging times!
AI Snips
Chapters
Transcript
Episode notes
Remote PhD Quals
- Hosts Andrey and Sharon discuss adapting to shelter-in-place in the Bay Area.
- Sharon successfully completed her PhD qualifying exams remotely via Zoom.
AI in Drug Discovery
- AI helps predict drug efficacy against COVID-19 by analyzing chemical sequences and molecular structures.
- Clinical trials remain essential for validating AI predictions.
AI in Medical Decisions
- AI can support medical decisions but shouldn't make life-or-death choices independently.
- Doctors should consider AI predictions alongside other factors when allocating limited resources.